U.S. Clinical Trial: Fox Chase Cancer Center Listed a New Clinical Trial of MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma

Press/Media

PeriodAug 16 2024

Media coverage

1

Media coverage

  • TitleU.S. Clinical Trial: Fox Chase Cancer Center Listed a New Clinical Trial of MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date08/16/24
    PersonsMarcus Messmer